Health guide

Weight that will not move

You've been careful with food for months. The scale barely moves — or it moves, then snaps right back. Meanwhile the thoughts about the next meal never really shut off. If that's familiar, you're far from alone. Stuck weight can sit next to a lot of different things — medications, short sleep, hormones, how the body handles glucose, the kind of food noise that keeps going after you've already eaten — sometimes more than one at once. This page walks through what those pieces mean in plain language, including when a normal A1C still isn't the whole metabolic story, and what a GLP-1 conversation in clinic actually covers.

Educational only: This page is for general education—not personal medical advice, diagnosis, or treatment. See a licensed clinician for your situation.

Weight that stays stuck

Weight that does not change despite serious effort is a medical complaint, not a character finding. Prediabetes — glucose or A1C in an intermediate range, short of diabetes — is associated with obesity, especially fat carried in the abdomen, and with higher cardiovascular risk. 1

None of that assigns a person a diagnosis from a story about the scale. Classification of diabetes and prediabetes uses laboratory tests done with a proper method:

  • A1C
  • Fasting glucose
  • A glucose tolerance test

1 A visit is an evaluation, not a promise of a prescription.

What this page covers—and what it does not

Covers:

  • Common contributors that travel with stuck weight
  • Food noise as a patient description (not a guideline diagnosis)
  • Why a normal A1C is not a clean bill of metabolic health
  • What a GLP-1 conversation in clinic usually covers
  • What to bring and what to raise in a weight visit

Does not cover:

  • A personal diagnosis
  • Dosing
  • A promise that a medicine will be prescribed
  • A full workup for every possible secondary cause

What often sits under stuck weight

More than one of these can be true at once. Naming them does not diagnose you.

  • Medications. Endocrine Society guidance treats drug-related weight gain as a preventable contributor and recommends weight-neutral or weight-losing options when clinically reasonable. Classes that often come up include insulin and some other diabetes medicines, certain antidepressants and antipsychotics, corticosteroids, and some antihistamines and injectables. Alternatives belong in a visit—not on this page. 3
  • Short sleep. Across population studies, short sleep duration is associated with higher odds of obesity in adults (pooled OR about 1.55 in one large meta-analysis). Association is not proof that short sleep caused any one person’s weight change. 4
  • Hormones. Hypothyroidism can include weight gain among other nonspecific symptoms and needs blood testing to confirm. 5 Low testosterone in men is diagnosed from symptoms plus repeatedly low morning levels—not from weight alone. 6 Cycle changes and the menopause transition belong in the history when weight shifted with midlife symptoms.
  • How the body handles glucose. Type 2 diabetes is described as loss of adequate insulin secretion, often on a background of insulin resistance. Prediabetes names glucose or A1C values between normal and diabetes. Obesity—especially abdominal fat—clusters with that spectrum and with higher cardiovascular risk. 1
  • Food noise. Some adults describe food thoughts that continue after eating and feel different from ordinary hunger. That description is not a diagnosis in diabetes or obesity guidelines. Appetite and weight are among the effects studied for GLP-1 medicines used for overweight and obesity; whether those medicines quiet food thoughts for a given person is not something a page can say. 2

Food noise

“Food noise” is a patient description for food thoughts that keep going after eating and do not feel like ordinary hunger. It is not a guideline diagnosis. If those thoughts include binge eating, that is assessed in a visit, not from a label. Whether a GLP-1 medicine changes food-related thoughts for a given person is also a visit question. 2

Insulin resistance, including a normal A1C

Type 2 diabetes is described as loss of adequate insulin secretion, often on a background of insulin resistance. Prediabetes is the term for glucose or A1C values between the normal range and diabetes. An A1C below 5.7% is the range the American Diabetes Association treats as normal for that test, not as a complete description of metabolic health. 1

Insulin resistance is not diagnosed by A1C alone. People can have metabolic risk while screening glucose is still outside the diabetes range. A normal A1C does not rule out insulin resistance — and it is not proof that insulin resistance is present. Separating a normal screen from a normal metabolism is a clinician’s job, using history and the right tests. 1

What a GLP-1 conversation covers

Guidelines discuss adding an anti-obesity medicine to lifestyle measures for adults who meet defined weight-related criteria and have not had an adequate response to lifestyle measures alone. The choice of medicine depends on:

  • The clinical picture
  • Other conditions
  • Contraindications
  • What the person prefers and can access

2

The American Gastroenterological Association’s 2022 guideline discusses that step for adults with a body mass index of 30 kg/m² or higher, or 27 kg/m² or higher when weight-related complications are also present, and lifestyle measures alone have not been enough. 2 Those figures describe who the guideline was written about. This is not your result. This page does not say that a GLP-1 medicine is appropriate for the reader.

In the liraglutide trials the AGA reviewed, nausea and vomiting were more common than with lifestyle measures alone, mostly in the first four to six weeks while the dose was increasing. 2 Nausea is a reason to contact the prescribing clinician, not a home plan for changing the dose. Vomiting that will not stop, severe abdominal pain, or signs of dehydration need urgent care. Food thoughts that return after a quiet stretch are a visit question — not proof the medicine failed, and not a character finding.

What to bring to a weight visit

A short set of notes beats a vague “nothing works” in the exam room. Bring what you have:

  • Weight history: highest and lowest adult weights you remember; when the stuck period started; any sharp jumps after pregnancy, injury, job change, or a new medicine.
  • Medication list: prescriptions, over-the-counter medicines, and supplements — including start dates when you know them.
  • Food-noise notes: a few days of when food thoughts stay loud after eating, versus ordinary hunger, and whether binge episodes are part of the picture.
  • Sleep pattern: typical bedtime and wake time, whether nights feel restorative, and any snoring, gasping, or witnessed pauses.

What to discuss with your doctor

  • How long weight has been stuck, and what you have already tried.
  • Whether a medication change lined up with the gain or plateau.
  • Sleep quantity and quality, including unrefreshing nights.
  • Cycle changes, menopause-transition symptoms, or symptoms that raise a question of low thyroid or low testosterone.
  • Whether food thoughts feel intrusive, and whether binge eating is a concern.
  • Prior labs (A1C, fasting glucose, lipids, thyroid) and whether “normal” results were treated as the end of the story.
  • Whether an anti-obesity medicine conversation fits your picture — without assuming a prescription is the outcome.
  • Urgent-care red flags: chest pain, severe shortness of breath, fainting, or vomiting that will not stop on a weight-related medicine.

Go deeper on a related topic

References

  1. American Diabetes Association Professional Practice Committee. 2. Diagnosis and classification of diabetes: Standards of Care in Diabetes—2026. Diabetes Care. 2026;49(Suppl 1):S27–S49. https://diabetesjournals.org/care/article/49/Supplement_1/S27/163926/2-Diagnosis-and-Classification-of-Diabetes
  2. Grunvald E, et al. AGA clinical practice guideline on pharmacological interventions for adults with obesity. Gastroenterology. 2022;163(5):1198–1225. https://www.gastrojournal.org/article/S0016-5085(22)01026-5/fulltext
  3. Apovian CM, et al. Pharmacological management of obesity: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(2):342–362. https://doi.org/10.1210/jc.2014-3415
  4. Cappuccio FP, et al. Meta-analysis of short sleep duration and obesity in children and adults. Sleep. 2008;31(5):619–626. https://pmc.ncbi.nlm.nih.gov/articles/PMC2398753/
  5. American Thyroid Association. Hypothyroidism. https://www.thyroid.org/hypothyroidism/
  6. Bhasin S, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715–1744. https://academic.oup.com/jcem/article/103/5/1715/4939465